Lineage Cell Therapeutics, Inc. (LCTX)
1.81
+0.03
(+1.69%)
USD |
NYAM |
Feb 20, 16:00
1.81
0.00 (0.00%)
After-Hours: 20:00
Lineage Cell Therapeutics Market Cap : 416.89M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nephros, Inc. | 43.36M |
| ProKidney Corp. | 295.83M |
| ACADIA Pharmaceuticals, Inc. | 4.059B |
| Agenus, Inc. | 110.59M |
| Alnylam Pharmaceuticals, Inc. | 44.59B |
Market Cap Related Metrics
| PS Ratio | 37.81 |
| PEG Ratio | -0.036 |
| Price to Book Value | 18.92 |
| Price | 1.81 |
| Earnings Yield | -16.39% |
| PEGY Ratio | -0.036 |